As a new-type foreign trade service provider driven by both technology commercialization and foreign trade, HiSiaddi has established a service system summarized as “1+2+3+4=1” and can supply dibenzyl ether sourced from multiple well-known original manufacturers. Possessing R&D capabilities, HiSiaddi has conducted multiple rounds of on-site inspections of dibenzyl ether manufacturers relying on technological cooperation with factories, developing objective and in-depth understanding of different brands. It frequently analyzes various dibenzyl ether manufacturers for clients to help them select matching products. Below is a brand recommendation case.
Contact HiSiaddi customer service for more comparative analysis of brands and models.
HEC Finechem GmbH of Germany is a time-honored fine chemical API enterprise headquartered in Bavaria with over 30 years of experience in high-end polypeptide and antifungal API R&D and manufacturing, supplying products to regulated pharmaceutical markets across the EU and North America. Dibenzyl ether is used as a high-purity solvent dedicated to hydroxyl protection in pharmaceutical synthesis, previously sourced from original pharmaceutical-grade BASF material, with an annual stable procurement volume of 90 tons. Products must rigorously comply with the European Pharmacopoeia (EP), REACH registration and ICH impurity control standards, imposing stringent requirements on raw material impurities, rectification precision, batch consistency and supporting test documentation—representing a typical high-end European pharmaceutical purchaser.
The client planned to replace original BASF dibenzyl ether with domestic alternatives and independently contacted five leading domestic dibenzyl ether manufacturers for sampling and quotations, yet fell into a product selection dilemma: sales representatives of each manufacturer only promoted their own branded products, avoiding discussion of competitor advantages while overemphasizing their own product strengths. The client could not horizontally benchmark true indicators and process differences across brands, nor distinguish between pharmaceutical-grade, refined industrial-grade and ordinary by-product grades. Multiple submitted samples failed impurity testing and triggered synthetic by-product excess, delaying final supplier brand confirmation. The client therefore entrusted HiSiaddi to conduct neutral full-brand research, model screening and full implementation of supplier selection.
HiSiaddi screened the top five mainstream domestic manufacturers of dibenzyl ether: Jiangsu Hualun, Zhejiang Lianhua, Shandong NHU, Hubei Jushun and Guangdong Wengjiang. Production capacity, process routes, parameters of three core sub-grades and respective advantages/disadvantages were sorted one by one to objectively summarize genuine strengths and weaknesses of each brand, breaking the information barrier created by manufacturers’ self-promotional sales tactics.
Flagship models: HL-98 General Industrial Grade, HL-995 Refined Grade, HL-998EP Customized Pharmaceutical Grade
· Advantages: Continuous negative-pressure rectification production lines, leading market share in pharmaceutical-grade sub-sector; HL-998 benzaldehyde impurity ≤8ppm, complete full-component GC chromatograms available, EP Pharmacopoeia-aligned test reports issuable, suitable for high-end pharmaceutical synthesis;
· Disadvantages: High minimum order quantity for customized small batches (minimum single order of 3 tons); no refined control of peroxide indicators for standard HL-995 grade.
Flagship models: LH-A General Industrial Grade, LH-PH Pharmaceutical Refined Grade
· Advantages: Long-term supply to Indian and European cross-border pharmaceutical groups with self-produced benzyl alcohol raw materials enabling source purity control; LH-PH maintains stable color APHA ≤10, complete REACH pre-registration documentation and abundant export experience;
· Disadvantages: Primary focus on large-tonnage bulk orders; 7~10-day sample scheduling lead time for small batches; no micro-adjustment of trace impurities available for personalized high-end customization, with limited flexibility for bespoke requirements.
Flagship models: XHC-98 National Standard Industrial Grade, XHC-MED Pharmaceutical Grade
· Advantages: Closed-loop full industrial chain production; warehouse and quality inspection systems benchmarked against European and American pharmaceutical enterprise audits; XHC-MED exhibits excellent anti-oxidation stability, resisting oxygen absorption and deterioration under ambient storage, suitable for long-term client inventory stockpiling;
· Disadvantages: Premium pricing for pharmaceutical-grade products, 7%~9% higher than Hualun for identical indicators; significant impurity fluctuations in general industrial-grade variants, not recommended for pharmaceutical synthesis applications.
Flagship models: JS-95 By-Product Rectified Grade, JS-98 Premium Industrial Grade
· Advantages: Low pricing and sufficient supply capacity, suitable for plasticizers and ordinary fragrance solvents;
· Disadvantages: Adopts benzyl alcohol by-product recovery rectification process, unable to deeply remove trace benzyl chloride and peroxide impurities; lacks pharmaceutical-grade production qualifications and cannot meet pharmacopoeia requirements for pharmaceutical manufacturing.
Flagship models: WJ-97 Reagent Subpackaged Grade, WJ-98 Industrial Drum Grade
· Advantages: Flexible small sample subpackaging with readily available 500g~25kg small packaging for laboratory trials;
· Disadvantages: No ten-thousand-ton continuous rectification facilities, significant batch-to-batch indicator fluctuations for mass production; unable to fulfill continuous mass production orders of dozens of tons, only suitable for laboratory R&D trial stages.
1. Information asymmetry: All manufacturers only highlight strengths of their own products while concealing grade weaknesses; clients cannot distinguish latent impurity gaps between products labeled with identical purity values (dibenzyl ether manufactured via by-product rectification vs. continuous rectification exhibit impurity levels differing dozens of times despite identical labeled 99.5% purity);
2. Confusing grade naming: No unified national standard naming convention for dibenzyl ether grades marked 99.5%, with manufacturers arbitrarily labeling product classes; clients cannot determine pharmaceutical suitability solely based on purity indicators;
3. Blind spots in supporting documentation: While some manufacturers produce high-purity products, they cannot issue EP-compliant English CoAs, SDS or full impurity chromatograms, failing to meet QA warehouse admission compliance standards of German pharmaceutical enterprises.
Combining the client’s API synthesis workflow, annual 90-ton procurement volume, EP Pharmacopoeia standards and phased on-demand production scheduling core requirements, Hubei Jushun and Guangdong Wengjiang (industrial-process manufacturers) were eliminated, with two mid-to-high-end brands (Jiangsu Hualun and Zhejiang Lianhua) selected and three sub-grades implemented for segmented production scenarios matching the client’s operations:
1. HL-998 EP Pharmaceutical Grade (Primary Mass Production Grade): Main raw material for client workshop large-scale manufacturing, purity ≥99.85%, benzyl alcohol ≤90ppm, benzyl chloride ≤18ppm, peroxides ≤3ppm, complete EP test chromatograms, English CoAs and full EDMF supporting documentation available, matching the client’s core API mass production with annual primary procurement of 75 tons;
2. HL-995 Refined Grade (R&D Lab Trial Material): Cost-effective premium option exceeding national standard refined product indicators, for client laboratory small trials and new process formula debugging, with annual procurement of 10~12 tons.
LH-PH Pharmaceutical Refined Grade (Backup Alternate Grade): Indicators closely aligned with HL-998 and superior warehouse anti-oxidation performance, serving as backup replenishment during Hualun capacity shortages in peak production seasons, with fixed annual stockpiling of 3~5 tons to guarantee uninterrupted supply chains.
Elimination Note: Shandong NHU XHC-MED meets indicator requirements yet carries higher procurement costs, abandoned for primary supply following client cost calculation, retained only as a backup quotation option.
1. Targeted sample testing per grade: HiSiaddi coordinated sample procurement of 25kg from each grade of the two manufacturers, shipped uniformly to the client’s German headquarters laboratory alongside Chinese-English bilingual indicator comparison tables and production process documentation compiled by HiSiaddi;
2. Full laboratory validation by client: The client completed three rounds of synthetic lab trials, confirming HL-998 and LH-PH pharmaceutical grades perfectly matched the original synthesis process with side reaction and impurity data benchmarking original BASF imported material, while HL-995 was suitable for R&D formula testing;
3. Finalization of annual framework contract: A combined procurement plan prioritizing HL-998 primary supply, LH-PH backup stock and HL-995 R&D auxiliary material was signed, establishing a 90-ton annual framework contract with monthly split production scheduling;
4. End-to-end documentation & quality control guarantee by HiSiaddi: Prior to each shipment, HiSiaddi pre-verifies CoAs and impurity chromatograms to ensure all documentation complies with German customs and pharmaceutical enterprise warehouse admission compliance standards.
1. Optimized procurement costs: Comprehensive average procurement price of the three domestic grades decreased by 27.3% compared to original BASF imports, cutting annual raw material procurement expenses by over 128,000 Euros;
2. Stable supply chain implementation: The first 45-ton order shipped to Germany in two consignments cleared customs and entered warehouses without incident. Six consecutive monthly production batches passed the client’s QA one-time full testing with zero raw material abnormalities;
3. Deepened long-term cooperation: The client entrusted HiSiaddi with priority brand screening and grade benchmarking for modified benzyl ether derivatives required by its pipeline new drugs;
4. Client internal supplier selection standard established: Leveraging the brand strength & weakness archive compiled by HiSiaddi, the client formulated internal dibenzyl ether grade access specifications, adopting this HiSiaddi rating framework for all new supplier evaluations moving forward.
1. No mandatory unified national standard naming convention exists for domestic dibenzyl ether grades, with each manufacturer adopting proprietary grade standards and sales teams adopting self-interested promotional tactics—this constitutes the biggest obstacle for overseas high-end clients conducting independent supplier selection;
2. Core Value of HiSiaddi: Adopting a neutral third-party perspective unbound by single manufacturer interests, horizontally dissecting advantages and disadvantages across the full industrial chain of brands, and segmenting grades precisely per end-user application scenarios to help high-end clients avoid procurement traps where “labeled purity meets standards yet latent impurities exceed limits”;
3. Core Procurement Logic of European and American High-End Pharmaceutical Enterprises: Product grade compatibility takes precedence over pure high purity and low pricing; process matching capability, complete compliance documentation and consistent batch quality represent top priorities for brand selection.
Contact HiSiaddi customer service for more comparative analysis of brands and models.
+86-13120989737 
info@hisiaddi.com 
English
